Response to the letter titled "Targeting dementia prevention with semaglutide: the case for APOE4 homozygotes"
Alzheimers Dement
.
2025 Jun;21(6):e70423.
doi: 10.1002/alz.70423.
Author
Rong Xu
1
Affiliation
1
Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
PMID:
40572020
PMCID:
PMC12202463
DOI:
10.1002/alz.70423
No abstract available
Publication types
Letter